Avidity Partners Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.15M | Buy |
134,000
+77,000
| +135% | +$4.11M | 1.42% | 24 |
|
|
2025
Q1 | $2.31M | Sell |
57,000
-25,000
| -30% | -$1.01M | 0.44% | 48 |
|
|
2024
Q4 | $2.28M | Buy |
+82,000
| New | +$2.28M | 0.22% | 55 |
|
|
2024
Q1 | – | Sell |
-235,000
| Closed | -$5.49M | – | 89 |
|
|
2023
Q4 | $5.49M | Sell |
235,000
-504,100
| -68% | -$11.8M | 0.2% | 63 |
|
|
2023
Q3 | $37.4M | Sell |
739,100
-285,900
| -28% | -$14.5M | 1.51% | 31 |
|
|
2023
Q2 | $47.9M | Sell |
1,025,000
-1,422,000
| -58% | -$66.4M | 1.67% | 21 |
|
|
2023
Q1 | $93.6M | Sell |
2,447,000
-1,378,000
| -36% | -$52.7M | 3.11% | 7 |
|
|
2022
Q4 | $210M | Buy |
3,825,000
+703,000
| +23% | +$38.5M | 4.54% | 4 |
|
|
2022
Q3 | $106M | Buy |
+3,122,000
| New | +$106M | 2.16% | 12 |
|